Innova Captab Ltd (INNOVACAP) is currently trading at 1,142.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Innova Captab Limited is an integrated pharmaceutical company engaged in CDMO services, as well as domestic and international branded generics. It operates comprehensive manufacturing units producing various dosage forms across multiple therapeutic areas. The company has shown a robust financial performance with a 42% YoY revenue growth in Q3 FY26, driven by accelerated expansion in both CDMO and branded generics sectors, particularly with substantial contributions from its Jammu facility. Innova Captab's manufacturing capabilities are bolstered by recent certifications including UK-MHRA for its Baddi facility and PIC/s for its Jammu facility, aligning with global standards for quality pharmaceuticals production. The company is strategically focusing on expanding its geographic reach, demonstrated by exports constituting 35% of their revenue in Q3 FY26, showcasing their increasing presence in the global market. Recent capacity expansions and greenfield projects in Jammu are part of the company's aggressive growth strategy, aiming for increased production capacity and operational scale in the coming years.

Over the past 52 weeks, Innova Captab Ltd has traded between a low of ₹608.25 and a high of ₹1,200.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Innova Captab Ltd has a market capitalization of approximately 6,556.26. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Innova Captab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 42.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 6,556.26 Cr, Innova Captab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Innova Captab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Innova Captab Ltd is 42.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The company revised results after identifying inadvertent accounting errors, mainly involving deferred tax liabilities linked to a historical business combination and a deferred tax asset under Section 80JJAA.

The company said it identified inadvertent accounting errors, mainly involving deferred tax items and the classification of supplier finance balances, and approved revised audited results for FY26 and Q4FY26.

The company said it identified inadvertent accounting errors, mainly linked to deferred tax liabilities from a historical business combination and recognition of a deferred tax asset under Section 80JJAA.

The board meeting was scheduled for August 11, 2026 to approve unaudited standalone and consolidated results for the quarter ended June 30, 2026 and to consider revised audited standalone results for FY ended March 31, 2026.